Science Applications International Corporation SAIC
132.61
0.18
0.14%
as of 25 Sep
- Market cap
- $5.6B
- P/E
- 15.4×
Follow SAIC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
11.91 | 13.03 | 10.82 | 13.57 |
P/S ratio |
0.59 | 0.64 | 0.58 | 0.67 | |
P/FCF ratio |
10.07 | 8.09 | 7.01 | 8.02 | |
P/Operating CF |
33.34 | 18.10 | 33.30 | 34.02 | |
P/B ratio |
2.84 | 3.11 | 2.97 | 3.46 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.92 | 0.96 | 0.91 | 0.99 | |
EV/EBITDA |
10.05 | 10.41 | 9.02 | 9.78 | |
EV/Operating CF |
14.47 | 11.45 | 10.39 | 11.10 | |
EV/FCF |
15.79 | 12.09 | 10.96 | 11.83 | |
Quick Ratio |
1.04 | 1.05 | 1.03 | 1.06 | |
Current Ratio |
1.20 | 1.20 | 1.16 | 1.20 | |
Net Debt/EBITDA |
14.71 | 13.32 | 10.85 | 12.35 | |
Debt/Assets |
45.86% | 46.45% | 46.57% | 45.82% | |
Debt/Equity |
1.64 | 1.66 | 1.75 | 1.73 | |
Asset Turnover |
1.37 | 1.37 | 1.38 | 1.39 | |
Operating CF/Net income |
1.65 | 3.04 | 1.10 | 1.43 | |
Capex/Depreciation |
(0.24) | (0.20) | (0.22) | (0.38) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.41% | 4.86% | 4.35% | 4.63% | |
Intangible Assets out of Total Assets |
0.69 | 0.69 | 0.69 | 0.67 | |
Share Based Compensation of Revenue |
1.39% | 0.74% | 0.68% | 0.80% | |
Graham Net Nets |
(0.62) | (0.57) | (0.64) | (0.55) | |
Graham Number |
76.37 | 75.11 | 80.93 | 81.09 | |
Earnings Yield |
8.40% | 7.67% | 9.24% | 7.37% | |
Free Cash Flow Yield |
9.93% | 12.35% | 14.26% | 12.46% | |
Revenue per Share |
40.65 | 37.80 | 43.62 | 44.34 | |
Operating CF per Share |
2.81 | 5.57 | 2.91 | 3.44 | |
Capex per Share |
(0.20) | (0.17) | (0.21) | (0.35) | |
Free Cash Flow per Share |
2.61 | 5.40 | 2.70 | 3.09 | |
Cash per Share |
0.98 | 3.93 | 2.49 | 2.97 | |
Shareholders Equity per Share |
32.94 | 32.40 | 32.56 | 33.87 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
32.94 | 32.40 | 32.56 | 33.87 | |
Free Cash Flow |
120.00 | 250.00 | 118.00 | 131.00 | |
Working Capital |
207.00 | 197.00 | 162.00 | 217.00 | |
Capital Expenditures |
(9.00) | (8.00) | (9.00) | (15.00) | |
Net Current Asset Value |
(2,654.00) | (2,675.00) | (2,716.00) | (2,708.00) | |
EV/EBIT |
12.82 | 13.39 | 11.41 | 12.37 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | |
Net Profit Margin |
4.18% | 4.86% | 6.03% | 5.43% | |
Price to Operating Income |
8.18 | 8.97 | 7.30 | 8.39 | |
| Other line items | |||||
Average Receivables |
1,033.50 | 926.50 | 985.50 | 973.50 | |
Average Payables |
670.50 | 565.50 | 651.00 | 577.00 | |
Average Assets |
5,349.00 | 5,300.00 | 5,274.50 | 5,312.00 | |
Average Common Equity |
1,562.00 | 1,538.50 | 1,464.00 | 1,476.50 |
Columns are period end dates